| Inhibition of mTORC1/2 overcomes resistance to MAPK pathway inhibitors mediated by PGC1α and oxidative phosphorylation in melanoma YNV Gopal, H Rizos, G Chen, W Deng, DT Frederick, ZA Cooper, ... Cancer research 74 (23), 7037-7047, 2014 | 79 | 2014 |
| Molecular profiling of patient-matched brain and extracranial melanoma metastases implicates the PI3K pathway as a therapeutic target G Chen, N Chakravarti, K Aardalen, AJ Lazar, MT Tetzlaff, B Wubbenhorst, ... Clinical Cancer Research 20 (21), 5537-5546, 2014 | 78 | 2014 |
| RMEL3, a novel BRAFV600E-associated long noncoding RNA, is required for MAPK and PI3K signaling in melanoma L Goedert, CG Pereira, J Roszik, JR Plaça, C Cardoso, G Chen, W Deng, ... Oncotarget 7 (24), 36711, 2016 | 21 | 2016 |
| Novel primate-specific genes, RMEL 1, 2 and 3, with highly restricted expression in melanoma, assessed by new data mining tool JF Sousa, R Torrieri, RR Silva, CG Pereira, V Valente, E Torrieri, ... PloS one 5 (10), e13510, 2010 | 18 | 2010 |
| Different isolates from Leishmania braziliensis complex induce distinct histopathological features in a murine model of infection CG Pereira, ALN Silva, P de Castilhos, EC Mastrantonio, RA Souza, ... Veterinary parasitology 165 (3-4), 231-240, 2009 | 18 | 2009 |
| Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation BCMF Paes, PD Moco, CG Pereira, GS Porto, EM de Sousa Russo, ... Cell biology and toxicology 33 (3), 233-250, 2017 | 15 | 2017 |
| A typical presentation of cutaneous leishmaniasis after renal transplantation FA Vinhal, SR Afonso-Cardoso, AG Silva, CG Pereira, W Sousa, ... Nephrology Dialysis Transplantation 22 (12), 3674-3674, 2007 | 10 | 2007 |
| Patent mining and landscaping of emerging recombinant factor VIII through network analysis CG Pereira, V Picanco-Castro, DT Covas, GS Porto Nature biotechnology 36 (7), 585-590, 2018 | 6 | 2018 |
| The scientific information provided through patents and its limited use in scientific research at universities CG Pereira, RR Da Silva, GS Porto Brazilian Journal of Science and Technology 2 (1), 2, 2015 | 5 | 2015 |
| Effects of Bothrops moojeni venom on Leishmania amazonensis promastigote forms P Castilhos, CG Pereira, ALN Silva, DR Napolitano, F Oliveira, MA Souza Journal of Venomous Animals and Toxins including Tropical Diseases 17 (2 …, 2011 | 5 | 2011 |
| Uncovering innovation features and emerging technologies in molecular biology through patent analysis CG Pereira, GS Porto Recombinant Glycoprotein Production, 15-34, 2018 | 3 | 2018 |
| The lncRNA RMEL3 protects immortalized cells from serum withdrawal‐induced growth arrest and promotes melanoma cell proliferation and tumor growth C Cardoso, RB Serafim, A Kawakami, C Gonçalves Pereira, J Roszik, ... Pigment cell & melanoma research 32 (2), 303-314, 2019 | 1 | 2019 |
| Technological cooperation network in biotechnology: Analysis of patents with Brazil as the priority country CG Pereira, RR Da Silva, JR Lavoie, GS Porto Innovation & Management Review 15 (4), 416-434, 2018 | 1 | 2018 |
| An IT Value Management Capability Model for Portuguese Universities: A Delphi Study C Pereira, C Ferreira, L Amaral Procedia computer science 138, 612-620, 2018 | 1 | 2018 |
| The involvement of heparin in retinal infection by Toxoplasma gondii in a chick model revealed an ontogenetic-dependent pattern EC Mastrantonio, CD Lopes, CG Pereira, NM Silva, BB Fonseca, ... Parasitology international 63 (2), 337-340, 2014 | 1 | 2014 |
| Reatividade sorológica de cães frente a antígenos de três espécies de Leishmania MM Tannus, FH RODRIGUES, E CÉSAR, FAR MASTRANTONIO, ... Horizonte Científico1 1, 1-28, 2007 | 1 | 2007 |
| Forecasting of emerging therapeutic monoclonal antibodies patents based on a decision model CG Pereira, JR Lavoie, E Garces, F Basso, M Dabić, GS Porto, T Daim Technological Forecasting and Social Change 139, 185-199, 2019 | | 2019 |
| Assessment of biotechnologies: a therapeutic monoclonal antibody emerging score CG Pereira, J Lavoie, E Garces, M Dabic, GS Porto, T Daim 2018 IEEE Technology and Engineering Management Conference (TEMSCON), 1-6, 2018 | | 2018 |
| RMEL3, a long noncoding RNA, induces tumor malignancy through the MAPK and PI3K pathways in BRAFV600E melanomas L Goedert, CG Pereira, J Roszik, JR Plaça, C Cardoso, G Chen, W Deng, ... Abstracts, 2016 | | 2016 |
| Influência de potenciais lncRNAs de expressão restrita ao melanoma (RMEL) na regulação de vias canônicas da melanomagênese CG Pereira, EM Espreafico | | 2014 |
Guo ChenMerck & Co.E-mail confirmado em merck.com